Indications and Purposes
| 1 Indications And Usage Ellence Is Indicated As A Component Of Adjuvant Therapy In Patients With Evidence Of Axillary Node Tumor Involvement Following Resection Of Primary Breast Cancer [See Clinical Studies (14.1) ] . Ellence Is An Anthracycline Topoisomerase Inhibitor Indicated As A Component Of Adjuvant Therapy In Patients With Evidence Of Axillary Node Tumor Involvement Following Resection Of Primary Breast Cancer ( 1 ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Epirubicin Hydrochloride |
|
ZINC5049216 |